Correction: Ferumoxytol (Feraheme) | The Medical Letter Inc.

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1336

April 19, 2010

View Complete Issue Table of Contents 2019

Correction: Ferumoxytol (Feraheme)

Download PDF: US English

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2010 Apr 19;52(1336):32

Disclosures

Objective(s)

Select a term to see related articles 2010 Anaphylaxis Anaphylaxis with intravenous iron Anaphylaxis with IV iron:1334 anemia April 19 chronic kidney disease CKD CKD treatment Correction: Ferumoxytol (Feraheme) — A New Parenteral Iron Formulation Dexferrum Dexiron dialysis Drugs for chronic kidney disease Drugs for CKD Elemental iron Feraheme Ferrlecit Ferumoxytol Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation High molecular weight iron Infed Infufer Intravenous iron iron Iron deficiency anemia Iron dextran Iron sucrose Issue 1334 Issue 1336 IV iron Low molecular weight iron March 22 page 23 Page 32 Parenteral iron Sodium ferric gluconate Treatment of chronic kidney disease Venofer volume 52

In the Medical Letter article on Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation (2010; 52:23), the last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1 gram of sodium ferric gluconate (Ferrlecit) as about $600.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.